In 1969, Drs. Rudy Soetikno, a young pharmacist serving in the Indonesian Army, noted the scarce supply of medicine around him. To alleviate this situation, he decided to utilise his knowledge of medicine, setting up a small pharmacy with friends to produce tablets. This small pharmacy rapidly acquired a reputation for producing highly effective prescription drugs, facilitating its expansion into other pharmaceuticals, facilities, and markets. By 1978, its products were available across all parts of Indonesia. Its name, “Dexa”, was derived from the Greek word for 10, a symbol of perfection.
Thus began Dexa Group, now among Southeast Asia’s largest pharmaceutical providers and a key strategic asset for Indonesia. The group applies its expertise in discovery, formulation, manufacturing, and marketing to supply highly sophisticated pharmaceuticals, nutraceuticals, supplements, and herbal medicines throughout Southeast Asia. It still maintains its trademark relentless emphasis on producing medicines of the highest quality. In fact, Dexa Group also works closely with the Indonesian Pharmaceutical Association to improve compliance standards across the entire industry.
Operationally, Dexa Group prioritizes four key areas:
- Resource Management
- Strategic Alliances
- Change Management
These priorities have helped Dexa consistently outperform the Indonesian pharmaceutical industry for over twenty-five years. In view of the burgeoning demand for its products, Dexa Group has redoubled its research, manufacturing, and marketing capabilities. Today, it comprises three renowned companies:
Ferron Par Pharmaceuticals
- Strive for excellence
A commitment to deliver the best possible value to customers
- Act professionally
An emphasis on honesty and integrity in all actions
- Deal with care
An effort to always understand and respect one another